AbbVie is one of the prominent fighters against COVID-19 since its outbreak. Before the global lockdown, ABBV has been indicating promising changes and on March 16 it reached the bottom. Within one month the shares had steep uptrend but recent changes have shown the slow decline. Poor financials? Partially, no. Last year’s report is demonstrating the good performances of net income and growing revenue. However, the liabilities start exceeding the assets thus making the stockholders’ equity negative.
If AbbVie’s revenue keeps growing its liabilities will diminish steadily. Short term focused traders will not wait unless they suddenly get paychecks that have a label “your dividends from ABBV”.
CEO and Editor in Chief.
Living in the era of dynamic tech change Asan decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring Finance) writing for technology and as well as finance has been one of the precious aspects of his life